Cefoxitin and Ototoxicity - a phase IV clinical study of FDA data
Ototoxicity is reported only by a few people who take Cefoxitin.
The phase IV clinical study analyzes which people take Cefoxitin and have Ototoxicity. It is created by eHealthMe based on reports of 561 people who have side effects while taking Cefoxitin from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
561 people reported to have side effects when taking Cefoxitin.
Among them, 2 people (0.36%) have Ototoxicity.
What is Cefoxitin?
Cefoxitin has active ingredients of cefoxitin sodium. eHealthMe is studying from 547 Cefoxitin users for its effectiveness, alternative drugs and more.
What is Ototoxicity?
Ototoxicity (damage to the ear) is found to be associated with 599 drugs and 337 conditions by eHealthMe.
Number of Cefoxitin and Ototoxicity reports submitted per year:
Gender of people who have Ototoxicity when taking Cefoxitin *:
- female: 50 %
- male: 50 %
Age of people who have Ototoxicity when taking Cefoxitin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 50 %
Common drugs people take besides Cefoxitin *:
- Vincristine Sulfate: 1 person, 50.00%
- Methotrexate Sodium: 1 person, 50.00%
- Gentamicin Sulfate: 1 person, 50.00%
- Cyclophosphamide: 1 person, 50.00%
Common side effects people have besides Ototoxicity *:
- Thrombocytopenia (decrease of platelets in blood): 1 person, 50.00%
- Ruptured Eardrum (tear in eardrum): 1 person, 50.00%
- Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 1 person, 50.00%
- Psychotic Disorder: 1 person, 50.00%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 50.00%
- Neurosensory Hypoacusis (a type of hearing loss in which the root cause lies in the vestibulocochlear nerve): 1 person, 50.00%
- Electrocardiogram Qt Prolonged: 1 person, 50.00%
- Drug Intolerance (drug sensitivity): 1 person, 50.00%
- Deafness Neurosensory: 1 person, 50.00%
- Confusional State: 1 person, 50.00%
Common conditions people have *:
- Mycobacterium Abscessus Infection (rapid growing bacterial infection): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Cefoxitin and have Ototoxicity?Check whether Ototoxicity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Ototoxicity and when was it recovered:
Expand to all the drugs that have ingredients of cefoxitin sodium:
Alternative drugs to, pros and cons of Cefoxitin:
- Cefoxitin (547 reports)
Ototoxicity treatments and more:
- Ototoxicity (1,631 reports)
COVID vaccines that are related to Ototoxicity:
- Ototoxicity in Moderna COVID Vaccine
- Ototoxicity in Pfizer BioNTech Covid Vaccine
- Ototoxicity in Johnson and Johnson Covid Vaccine
Common drugs associated with Ototoxicity:
All the drugs that are associated with Ototoxicity:
- Ototoxicity (599 drugs)
All the conditions that are associated with Ototoxicity:
- Ototoxicity (337 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cefoxitin sodium (the active ingredients of Cefoxitin) and Cefoxitin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Estrace and Sensory Disturbance - now
- Midazolam Hydrochloride and Aminocaproic drug interaction - 3 seconds ago
- Schizoaffective Disorder and High Blood Cholesterol - 4 seconds ago
- Quetiapine Fumarate and Lymphopenia - 9 seconds ago
- Ultracef and Aseptic Necrosis - 11 seconds ago
- Urinary Retention in Zolpidem Tartrate, how severe and when it was recovered? - 14 seconds ago
- Vitamin D and Gravol drug interaction - 16 seconds ago
- Pain and Insulin Resistant Diabetes - 19 seconds ago
- Lovenox and Trilipix drug interaction - 22 seconds ago
- Vitamins and Vertebral Artery Stenosis - 22 seconds ago